Shareholders’ Equity and Equity Compensation - Schedule of Options Vested and Expected to Vest (Details) - $ / shares		3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 03, 2025	Jun. 30, 2025	Jun. 30, 2024	Jun. 30, 2025	Jun. 30, 2024	Dec. 31, 2024
Number of Options
Unvested, beginning balance (in shares)				6,658,321
Granted (in shares)	1,530,000			3,085,295
Cancelled/forfeited (in shares)				(362,227)
Vested, outstanding shares (in shares)				(2,203,174)
Unvested, ending balance (in shares)		7,178,215		7,178,215		6,658,321
Early exercised unvested, end of period (in shares)		43,605		43,605
Weighted Average Exercise Price
Unvested, beginning balance (in dollars per share)				$ 15.79
Granted (in dollars per share)				18.79
Cancelled/forfeited (in dollars per share)				15.52
Vested (in dollars per share)				14.41
Unvested, ending balance (in dollars per share)		$ 17.52		17.52		$ 15.79
Early exercised unvested, end of period (in dollars per share)		16.20		16.20
Weighted Average Exercise Price
Unvested, beginning balance (in dollars per share)				9.39
Granted (in dollars per share)		14.02	$ 11.76	15.43	$ 11.76
Cancelled/forfeited (in dollars per share)				9.62
Vested, outstanding shares (in dollars per share)				8.88
Unvested, ending balance (in dollars per share)		12.13		12.13		$ 9.39
Early exercised unvested, end of period (in dollars per share)		$ 10.37		$ 10.37
Weighted Average Remaining Contract Term
Unvested outstanding, as of December 31, 2024				3 years 4 months 2 days		3 years 3 months 18 days
Unvested outstanding, as of June 30, 2025				3 years 4 months 2 days		3 years 3 months 18 days